|
|
Media (Standard Deviation)/ n(%)
Median (1º,3º Quartile).
|
Gender
|
Male
Female
|
28 (26.42%)
78 (73.58%)
|
Age (Years)
|
15-39
40-49
50-59
60-79
ᐳ 80
|
9 (8.49%)
10 (9.43%)
30 (28.3%)
52 (49.06%)
5 (4.72%)
|
Samter´s Triad
|
Yes
No
|
14 (13.21%)
92 (86.79%)
|
Nasal Polyps
|
Yes
No
|
22 (20.75%)
84 (79.25%)
|
ABPA
|
Yes
No
|
4 (3.77%)
102 (96.23%)
|
Type of Asthma
|
Allergic Asthma
Nonallergic asthma
Missing variables
|
52 (50%)
52 (50%)
2 (1.89%)
|
Inhaled corticosteroid dose*
|
Low
Medium
High
Missing variables
|
29 (27.62%)
44 (41.9%)
32 (30.48%)
1 (0.94%)
|
Oral corticosteroid base treatment
|
Yes
No
|
4 (3.77%)
102 (96.23%)
|
Last FEV1 registered
|
≤ 50%
51-59%
60-80%
81-89%
≥90%
Missing variables
|
7 (7%)
6 (6%)
35 (35%)
14 (14%)
38 (38%)
6 (6%)
|
Comorbidities
(Age, DM, HT, DLP, Obesity, SAHS, Immunodeficiencies)
|
None
One
Two
Three or more
|
14 (13.21%)
23 (21.7%)
24 (22.64%)
45 (42.45%)
|
Need of medical assistance due to asthma symptoms during the last
year
|
Yes
No
|
44 (41.51%)
62 (58.49%)
|
Need of medical hospitalization due to asthma symptoms during the last
year
|
Yes
No
|
6 (5.66%)
100 (94.34%)
|